Skip to main content
. 2021 Feb 8;40(3):661–674. doi: 10.1007/s10555-020-09953-z

Table 1.

Germline variants and the risk of pancreatic cancer

Gene % of patients with pancreatic cancer Increased Risk Age 50+ Age 70
SEER USA population 1 0.05% 0.5%
Hereditary non-polyposis colorectal cancer (Lynch syndrome) genes < 1 7–8 0.4% 4%
ATM 1–4 6 0.3% 3%
BRCA2 2–7 2–6 Up to 0.3% Up to 3%
BRCA1 Up to 1 1–2.5 Up to 0.15%
PALB2 < 1 2.4 0.12% 1.2%
p16/CDKN2A 1–3 12–46 Up to 2.3% Up to 23%
PRSS1 < 1 50–60 3% 30%
STK11 < 1 75–135 6.75% Up to 67.5%
TP53 < 1 6–7 0.35% Up to 3.5%

+Using the high end of the range of increased risk